Search results
6 paź 2017 · Support for patients and carers in managing rheumatoid arthritis through education, self-management and the provision of information and advice. Location of review.
Objective. To develop updated guidelines for the pharmacologic management of rheumatoid arthritis. Methods. We developed clinically relevant population, intervention, comparator, and outcomes (PICO) questions.
24 paź 2024 · Gottenberg, J.-E. et al. Non-TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical trial.
10 sty 2024 · This comprehensive review explores the multifaceted landscape of rheumatoid arthritis (RA), encompassing its epidemiology, pathophysiology, clinical manifestations, diagnosis, treatment...
The ACC/AHA Joint Committee on Clinical Practice Guidelines has commissioned this guideline to focus on the evaluation of acute or stable chest pain or other anginal equivalents, in various clinical settings, with an emphasis on the diagnosis on ischemic causes.
2 gru 2022 · Background. Rheumatoid arthritis (RA)-associated interstitial lung disease (ILD) is common in patients with RA and leads to significant morbidity and mortality. No randomized, placebo-controlled data are available that support the role of immunosuppression to treat RA-associated ILD, despite being widely used in clinical practice. Research Question
ABSTRACT. Objectives To summarise, by a systematic literature review (SLR), the evidence regarding pharmacological and non- pharmacological therapeutic strategies in dificult- to- treat rheumatoid arthritis (D2T RA), informing the EULAR recommendations for the management of D2T RA.
